CL King Downgrades SurModics (SRDX) to Neutral
More News related to SRDX
- SurModics (SRDX) Misses Q4 EPS by 4c
- SurModics Reports Fourth Quarter and Fiscal Year 2009 Results
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment
- SurModics to Webcast Fourth Quarter and Fiscal Year 2009 Earnings Conference Call November 4
More News related to Downgrades
- S&P Announces Change to US Index: LL for UCBH
- Electronic Arts (ERTS) Makes Major Job Cuts As Q2 Profits Lag
- Kraft (KFT) to Ask Holders to Vote to Issue New Shares
- Sprint Nextel (S) Aims to Reduce Labor Costs by $350M in Q409
- Highlights From DISH's Q3 Conference Call - Q&A Session
CL King downgrades SurModics (Nasdaq: SRDX) from Accumulate to Neutral.
SurModics, Inc. engages in the development, manufacture, and sale of surface modification and drug delivery technologies to the healthcare industry.
Related Categories
DowngradesStocks Mentioned
-0.25Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
